Needham & Company LLC Reaffirms “Hold” Rating for ZimVie (NASDAQ:ZIMV)

ZimVie (NASDAQ:ZIMV)‘s stock had its “hold” rating restated by analysts at Needham & Company LLC in a report released on Thursday, Marketbeat reports.

ZimVie Stock Up 1.0 %

Shares of ZIMV stock opened at $12.65 on Thursday. ZimVie has a 52-week low of $11.41 and a 52-week high of $22.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The stock has a market cap of $350.11 million, a price-to-earnings ratio of -0.96 and a beta of 2.10. The firm’s 50-day moving average is $13.57 and its 200-day moving average is $14.48.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. Sell-side analysts predict that ZimVie will post 0.6 EPS for the current year.

Institutional Investors Weigh In On ZimVie

Institutional investors have recently modified their holdings of the business. Segall Bryant & Hamill LLC acquired a new stake in ZimVie in the 3rd quarter worth about $891,000. Barclays PLC raised its position in shares of ZimVie by 338.4% in the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock valued at $690,000 after buying an additional 33,529 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of ZimVie by 66.7% in the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock valued at $2,911,000 after buying an additional 73,395 shares during the period. Geode Capital Management LLC grew its position in ZimVie by 2.4% during the third quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock worth $10,263,000 after buying an additional 15,053 shares in the last quarter. Finally, Principal Financial Group Inc. bought a new position in ZimVie during the 3rd quarter worth $275,000. Institutional investors own 95.63% of the company’s stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.